Cargando…

A case series on tofacitinib-induced weight gain

Janus kinase inhibitor tofacitinib belongs to a group of targeted synthetic disease-modifying anti-rheumatic drugs, also known as small molecule inhibitors. They are oral drugs with a novel strategy to treat inflammatory diseases. The major concern with the use of these drugs is a high risk for infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Kanisha, Shukla, Dhaiwat, Patel, Manish, Malhotra, Supriya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657621/
https://www.ncbi.nlm.nih.gov/pubmed/37737080
http://dx.doi.org/10.4103/ijp.ijp_158_23